山东大学耳鼻喉眼学报 ›› 2015, Vol. 29 ›› Issue (5): 38-42.doi: 10.6040/j.issn.1673-3770.0.2015.143

• 论著 • 上一篇    下一篇

沉默HIF-1α基因对鼻黏膜上皮细胞生长因子表达的影响

李盈盈, 周涵, 张伟强, 董伟达   

  1. 南京医科大学第一附属医院, 江苏省人民医院耳鼻咽喉科, 江苏 南京 210029
  • 收稿日期:2015-04-07 修回日期:2015-07-09 出版日期:2015-10-16 发布日期:2015-10-16
  • 通讯作者: 董伟达,E-mail:weidadong2649@126.com;周涵,E-mail:zhouhan1979@sina.com E-mail:weidadong2649@126.com;zhouhan1979@sina.com
  • 作者简介:李盈盈,E-mail:liyingyer@yeah.net
  • 基金资助:
    国家自然科学基金(81200729)

Effects of silencing hypoxia inducible factor-1α on the expression of cytokines in cultured human nasal epithelial cells

LI Yingying, ZHOU Han, ZHANG Weiqiang, DONG Weida   

  1. Department of Otorhinolaryngology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Provence Hospital, Nanjing 210029, Jiangsu, China
  • Received:2015-04-07 Revised:2015-07-09 Online:2015-10-16 Published:2015-10-16

PDF (PC)

416

被引次数

3

摘要： 目的 采用短发夹 RNA(shRNA)特异性沉默人鼻黏膜上皮细胞(HNEC)缺氧诱导因子-1α (HIF-1α)基因,观察对其表达血管内皮生长因子(VEGF)、转化生长因子(TGF)β1、碱性成纤维细胞生长因子(bFGF) 的影响。方法 体外培养原代鼻黏膜细胞,设计合成以腺病毒为载体GFP标记的shRNA,将HNEC分为空白对照组、阴性对照组(ad-HIF shRNA-neg)、ad-HIF shRNA干扰组。采用RT-PCR和Western blotting技术检测转染后相应因子蛋白和mRNA的表达情况。结果 成功合成ad-HIF shRNA并转染入HNEC中。转染ad-HIF shRNA后,HIF-1α蛋白及mRNA表达分别下降40%和39%(q=31.469,16.590);同时VEGF、TGF-β1、bFGF的蛋白及mRNA表达也随之下降,差异均有统计学意义(P<0.05)。结论 HIF-1α mRNA的shRNA能有效地使HNEC的HIF-1α基因沉默,进而有效地抑制VEGF、TGF-β1和bFGF的表达, 提示HNEC中HIF-1α可能通过直接或间接途径调控着VEGF、bFGF和TGF-β1的表达。

关键词: 鼻黏膜, 血管内皮生长因子, 碱性成纤维细胞生长因子, 缺氧诱导因子-1, 转化生长因子β1, RNA干扰

Abstract: Objective To investigate the effects of silencing hypoxia inducible factor-1α(HIF-1α) by transfecting short hairpin RNA(shRNA)into cultured human nasal epithelial cells (HNECs) and its further regulations on vascular endothelial growth factor(VEGF), transforming growth factor(TGF)β1 and basic fibroblast growth factor(bFGF). Methods HNECs were isolated from 10 inferior turbinate-cutting patients'mucosa. Two HIF-shRNA fragments were built and the best silencing shRNA sequence was used for transfection. We separated cells into three groups: the blank group, the negative control group and the ad-HIFshRNA interference group. The protein and gene expressions were detected by Western blotting and PCR. Results HNECs were transfected with GFP marketed adenovirus which carry the best silencing HIF-1α shRNA. The protein and mRNA expressions of HIF-1α were significantly reduced 40% and 39%(q=31.469, 16.590), and following, the protein and mRNA expressions of VEGF, TGF-β1 and bFGF were reduced (P<0.05). Conclusion Transfection of ad-HIFshRNA can effectively silence the expression of HIF-1α gene and protein and furthermore inhibit the expressions of VEGF, TGF-β1 and FGF-2, which suggests HIF-1α regulates the expression of VEGF, bFGF and TGF-β1 through direct or indirect ways. Thus silencing HIF-1α may provide a new way towards allergic rhiniti's treatment.

Key words: Nasal epithilial cells, RNA interference, Hypoxia-inducible factor-1α, Transforming growth factor-β1, Vascular endothelial growth factor, Basic fibroblast growth factor

中图分类号: 

  • R765.2
[1] Baldea A J, Luchette F A. The role of hypoxia-inducible factor-1alpha in response to injury and hypoxia[J]. Crit Care Med, 2014, 42(10):2312-2313.
[2] Walmsley S R, Cadwallader K A, Chilvers E R. The role of HIF-1alpha in myeloid cell inflammation[J]. Trends Immunol, 2005, 26(8):434-439.
[3] Bollinger T, Gies S, Naujoks J, et al. HIF-1alpha-and hypoxia-dependent immune responses in human CD4+CD25high T cells and T helper 17 cells[J]. J Leukoc Biol, 2014, 96(2):305-312.
[4] Hirota S A, Beck P L, MacDonald J A. Targeting hypoxia-inducible factor-1 (HIF-1) signaling in therapeutics: implications for the treatment of inflammatory bowel disease[J]. Recent Pat Inflamm Allergy Drug Discov, 2009, 3(1):1-16.
[5] Sumbayev V V, Yasinska I, Oniku A E, et al. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils[J]. PloS One,2012, 7(3):e34259.
[6] Steinke J W, Woodard C R, Borish L. Role of hypoxia in inflammatory upper airway disease[J]. Curr Opin Allergy Clin Immunol, 2008, 8(1):16-20.
[7] Sumbayev V V, Nicholas S A. Hypoxia-inducible factor 1 as one of the "signaling drivers" of Toll-like receptor-dependent and allergic inflammation[J]. Arch Immunol Ther Exp (Warsz), 2010, 58(4):287-294.
[8] 杨琳红,董震.人鼻黏膜上皮细胞HIF-1α和VEGF的表达及意义[J].临床耳鼻咽喉头颈外科杂志, 2008, 22(8):341-345.YANG Linhong, DONG Zhen. Expression and the role of HIF-la and VEGF in human nasal epithelial cells[J]. J Clin Otolaryngol Head Neck Surgery, 2008, 22(8):341-345.
[9] Kim C H, Kim J K, Kim H J, et al. Comparison of intranasal ciclesonide, oral levocetirizine,and combination treatment for allergic rhinitis[J]. Allergy Asthma Immunol Res, 2015, 7(2):158-166.
[10] Meadows A, Kaambwa B, Novielli N, et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis[J]. Health Technol Assess [JP3](Winchester, England), 2013, 17(27):vi, xi-xiv, 1-322.
[11] Baay-Guzman G J, Bebenek I G, Zeidler M, et al. HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation[J]. Respirat Res,2012,13(1):60.
[12] Huerta-Yepez S, Baay-Guzman G J, Bebenek I G, et al. Hypoxia inducible factor promotes murine allergic airway inflammation and is increased in asthma and rhinitis[J]. Allergy, 2011, 66(7):909-918.
[13] Kim S R, Lee K S, Park H S, et al.HIF-1alpha inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium[J]. Eur J Immunol, 2010, 40(10):2858-2869.
[14] Zhou H, Chen X, Zhang W M, et al.HIF-1alpha inhibition reduces nasal inflammation in a murine allergic rhinitis model[J]. PloS One, 2012, 7(11):e48618.
[15] Lee K S, Kim S R, Park S J, et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis[J]. Am J Respirat Crit Care Med, 2008, 178(8):787-797.
[16] Mo J H, Kim J H, Lim D J, et al. The role of hypoxia-inducible factor 1alpha in allergic rhinitis[J]. Am J Rhinol Allergy, 2014, 28(2):e100-106.
[17] Park S J, Lee K S, Kim S R, et al. AMPK activation reduces vascular permeability and airway inflammation by regulating HIF/VEGFA pathway in a murine model of toluene diisocyanate-induced asthma[J]. Inflamm Res, 2012, 61(10):1069-1083.
[18] Capetandes A, Zhuang M, Haque F N, et al. Vascular endothelial growth factor is increased by human pulmonary cells stimulated with Dermatophagoides sp. extract[J]. Allergy Asthma Proc, 2007, 28(3):324-330.
[19] Kim S R, Lee K S, Lee K B, et al. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma[J]. Allergy, 2012, 67(7):869-877.
[20] Ganesan P, Matsubara K, Sugawara T, et al. Marine algal carotenoids inhibit angiogenesis by down-regulating FGF-2-mediated intracellular signals in vascular endothelial cells[J]. Mol Cell Biochem, 2013, 380(1-2):1-9.
[21] Yum H Y, Cho J Y, Miller M, et al. Allergen-induced coexpression of bFGF and TGF-beta1 by macrophages in a mouse model of airway remodeling: bFGF induces macrophage TGF-beta1 expression in vitro[J]. Inter Arch Allergy Immunol, 2011, 155(1):12-22.
[1] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[2] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[3] 王丽雪,曾毅,王丽欣,彭先兵. 浸润毕罗芬明胶海绵在功能性鼻内镜鼻窦手术后应用效果的临床观察[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 16-25.
[4] 徐恩沛,孙先勇. 渗出性年龄相关性黄斑变性并发视网膜色素上皮脱离的诊治进展[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 125-142.
[5] 王露萍,寇芳柠,王皓,张灿伟,王艳玲,尤冉,吴伟珍. 视网膜下高反射物质在抗VEGF治疗nAMD患者中对视力预后的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(6): 101-105.
[6] 李曼冯雪,王艳玲. 眼缺血综合征与缺血性脑卒中相关性研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 88-92.
[7] 樊慧娟，张海利. HIF-1α与VEGF在中耳胆脂瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 93-97.
[8] 刘志高,王淑雅,韩旭光,王玉,李志伟,马爱华,赵博军. 增殖性糖尿病视网膜病变术前玻璃体腔应用阿柏西普的时机及其疗效观察[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 99-103.
[9] 李萱, 黄映湘. 25例虹膜新生血管发生原因探讨[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 41-47.
[10] 戴飞,魏瑾瑾,汤欣玥,陈峥,蔺林. 2-APB体外抑制嗜中性粒细胞型鼻息肉中的炎症反应[J]. 山东大学耳鼻喉眼学报, 2020, 34(4): 97-100.
[11] 宋晓宇,宋西成. 缺氧诱导因子-1α在甲状腺癌中的调节机制[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 136-138.
[12] 涂雪峰. 重组牛碱性成纤维细胞生长因子联合玻璃酸钠治疗干眼症的疗效分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 84-87.
[13] 王驰,刘星,孔磊,洪兴和,宁博. 鼻内镜下等离子射频消融术对合并鼻窦炎的小儿腺样体肥大患者疗效及鼻腔黏膜纤毛清除功能的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 78-81.
[14] 甘彬,张永举,许安廷. BRF2在慢性鼻-鼻窦炎伴鼻息肉发病过程中的作用研究[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 47-53.
[15] 李浩,李延忠,王岩. HIF-1α、VEGF在阻塞性睡眠呼吸暂停低通气综合征患者[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 43-47.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发